Product Information

POTASSIUM CL ER 20 MEQ TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1351 per EA under NDC 31722013501. Its NADAC has been published 263 times since Aug 11, 2021.

FDA first approved this application on Dec 29, 2020. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 20 MEQ TABLET

Potassium Chloride
$0.1351per EA

Strength

1500 mg/1

NDC

31722013501

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA214422

FDA Approved

12/29/2020

TE Code

AB1

On Market Since

1/20/2021

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 20 MEQ TABLET has been published 263 times since Aug 11, 2021, and over the history we have for it it has declined 46.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1351 per EA
All-time high$0.2527 (Aug 11, 2021)
All-time low$0.1196 (Jul 17, 2024)
52-week high$0.1502
52-week low$0.1333
Median price$0.1521
Average price$0.1624
Largest weekly change-21.7% (Apr 17, 2024)
Weeks tracked263
Tracking sinceAug 11, 2021

Price History

1W

+1.3%

1M

+1.3%

3M

-1.2%

6M

-0.6%

1Y

-10.1%

3Y

-23.3%

5Y

-41.4%

All

-46.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 20 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 20 MEQ TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1351 per EA (NDC 31722013501), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 20 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has declined 46.6%. It has been tracked across 263 weekly CMS publications since Aug 11, 2021.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 20 MEQ TABLET?

Since Aug 11, 2021, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has ranged from a low of $0.1196 (Jul 17, 2024) to a high of $0.2527 (Aug 11, 2021), with a median of $0.1521 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 20 MEQ TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 20 MEQ TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 20 MEQ TABLET?

POTASSIUM CL ER 20 MEQ TABLET (NDC 31722013501) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.